RRML - Levels and diagnostic values of serum visceral adipose tissue-derived serine protease inhibitor and secreted frizzle-related protein 5 in children with idiopathic short stature
AMLR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Rejection rate (2020): 75%

Română English


Journal Metrics

Impact Factor 0.5
Five Year Impact Factor 0.5
JCI 0.12


Advanced search


Top 10 downloaded articles
- May 2024 -
 
A comprehensive review of Prof... 9
Diagnostic value of stress myo... 9
Effect of Systemic Inflammator... 8
Evaluation of routine laborato... 7
The role of nitro oxidative fa... 6
Correlations of expressions of... 6
Evaluation of cytotoxicity and... 6
Monitoring the sensitivity of ... 5
Anti-oxidized low-density lipo... 3
Immunophenotyping aspects of c... 3

Log in

Concept, Design & Programming
Dr. Adrian Man

   
 
Nr. 31(3)/2023 DOI:10.2478/rrlm-2023-0021
XML
TXT

Research article

Levels and diagnostic values of serum visceral adipose tissue-derived serine protease inhibitor and secreted frizzle-related protein 5 in children with idiopathic short stature

Ling Che, Lei Chen, Binlan Hou, Fei Ouyang, Huimei Zhou

Correspondence should be addressed to: Lei Chen

Abstract:

Background: Idiopathic short stature (ISS) is a common type of short stature. We aimed to analyze the diagnostic values of serum visceral adipose tissue-derived serine protease inhibitor (Vaspin) and secreted frizzle-related protein 5 (SFRP5) for ISS children. Methods: Sixty-five ISS children treated from February 2019 to June 2022 were selected as an ISS group, while another 65 healthy children receiving physical examination in the same period were selected as a healthy group. Their general data, physical development status, levels of serum Vaspin and SFRP5, and levels of serum growth hormone-releasing hormone (GHRH)/growth hormone (GH)/insulin-like growth factor-1 (IGF-1) axis-related indicators were compared. Results: The ISS group had lower body height, body weight, bone age, growth velocity and serum SFRP5 level and higher serum Vaspin level than those of the healthy group (P<0.05). The levels of serum GHRH, GH and IGF-1 were lower in the ISS group than those in the healthy group (P<0.05). Body height, body weight, bone age, growth velocity, and levels of GHRH, GH and IGF-1 were negatively correlated with serum Vaspin level (r<0, P<0.05) but positively correlated with serum SFRP5 level (r>0, P<0.05). The areas under the ROC curves of serum Vaspin and SFRP5 and their combination for the diagnosis of ISS were 0.871 [95% confidence interval (CI): 0.812-0.929], 0.880 (95% CI: 0.824-0.935) and 0.942 (95% CI: 0.907-0.977), respectively. Conclusions: Children with ISS have a higher level of serum Vaspin but a lower level of SFRP5, and the combined detection has a higher diagnostic value for ISS.

Keywords: child; idiopathic short stature; secreted frizzle-related protein 5; visceral adipose tissue-derived serine protease inhibitor

Received: 19.4.2023
Accepted: 17.7.2023
Published: 20.7.2023

 
  PDF Download full text PDF
(487 KB)
     
 
How to cite
Che L, Chen L, Hou B, Ouyang F, Zhou H. Levels and diagnostic values of serum visceral adipose tissue-derived serine protease inhibitor and secreted frizzle-related protein 5 in children with idiopathic short stature. Rev Romana Med Lab. 2023;31(3):205-12. DOI:10.2478/rrlm-2023-0021